Proliferative Diabetic Retinopathy (PDR) Completed Phase 3 Trials for Bevacizumab (DB00112)

Back to Proliferative Diabetic Retinopathy (PDR)

Also known as: PDR - Proliferative Diabetic Retinopathy / Diabetic Proliferative Retinopathy / Proliferative Diabetic Retinopathy / Proliferative retinopathy due to diabetes mellitus (disorder) / Retinopathy due to diabetes mellitus (disorder) / Diabetic retinopathy / Retinopathy diabetic

IndicationStatusPhase
DBCOND0056889 (Proliferative Diabetic Retinopathy (PDR))Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00545870
Bevacizumab Versus Ranibizumab for Diabetic RetinopathyTreatment
NCT00656435
Bevacizumab and Long Acting Gas in Diabetic VitrectomyTreatment